Skip to content
Catalyst

knowcompoundsbeta-cryptoxanthin

Specimen compound organic compoundPlate I

Beta-cryptoxanthin

Nested hairline contours trace the electron density of one computed shape of beta-cryptoxanthin, teal at the edge warming to amber over the atoms.

432 readings, by contour and atom

fig. 1Beta-cryptoxanthin · electron density · PubChem CID 5281235, computed 3D conformer
Formula
C40H56O
Molar mass
552.887 g/mol
PubChem CID
5281235
InChIKey
DMASLKHVQRHNES-FKKUPVFPSA-N

↓ lowered

01 · the evidence, ordered

What the evidence says

Fig. 2 Beta-cryptoxanthin CHEBI:10362 1 endpoint its finding
×1.60
Labels
CompoundInspector

Beta-cryptoxanthin

1 reference statement, not drawn · 36 compounds on the outer ring, not drawn

Keys

← → round a ring↑ ↓ out and inEnter selecte the outer ringf fit to view+ − zoomEsc clearclick a node to select it

02 · findings

What beta-cryptoxanthin moved, and by how much

  • MD mean difference. Brackets: the interval as reported.
  • Dose studied: as its paper gave it.
  • Evidence strength: computed from the study. How it is computed
  1. Alanine aminotransferaseMoved: lowersEffect, as reportedMD−9.6Evidence: ModeratePaper: PMID 330817172020
    Who
    Iranian overweight/obese adults with moderate-to-severe non-alcoholic fatty liver disease; the same 500 kcal/day-deficit normal-protein diet in both arms; intention-to-treat, multivariable-adjusted ANCOVA contrast against the control arm
    Dose studied
    6 mg/day β-cryptoxanthin, one 600 mg capsule (powder 1% β-cryptoxanthin, 99% starch) daily after dinner, 12 weeks

    In addition, patients in the β-cryptoxanthin group only showed a greater 12-week reduction in serum level of ALT, compared to those in the control group (for ALT: mean difference − 9.6 IU/L; p = 0.005).”

    Quoted verbatim from A hypocaloric high-protein diet supplemented with β-cryptoxanthin improves non-alcoholic fatty liver disease: a randomized controlled trial.RCT · 3 monthsPermalink

No dose is advised.

  • MD mean difference. Brackets: the interval as reported.
  • Dose studied: as its paper gave it.
  • Evidence strength: computed from the study. How it is computed

03 · identity

Structure

fig. 3Beta-cryptoxanthin · 2D structure · ChEBI’s SMILES
fig. 4Beta-cryptoxanthin · 3D conformer · PubChem CID 5281235, computed
Charge
0
SMILES
CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C2=C(C)C[C@@H](O)CC2(C)C)C(C)(C)CCC1

04 · reach

What it touches on the way

1 entity · assembled from reference reactions

  1. BCO2Protein7 paths · 7 endpointsinferred

05 · documented · reference

Interactions

Documented interactions
None reported

Pairs that share biology

What the reference databases state

Reference statements
101 ProteinBCO2inferred, one hop from beta-cryptoxanthin
Reactions · Rhea
4reactions
1Reference statement

What the reference databases state

Evidence key

Statements

1 statement

beta-cryptoxanthin is a substrate of each

4Reactions

06 · on the label · 171 products

Labelled products

Source: NIH DSLD · Ingredient: beta-cryptoxanthin · 171 products · Declared amount per serving: 8–10,000 µg

114 labels state an amount57 do not

  • Bronson LaboratoriesNatural Beta Carotene112 µgper 1 softgelDSLD:8527
  • Controlled LabsWhite Floodamount not statedper 6.1 gDSLD:2637
  • CTD SportsMulti Eliteamount not statedper 1 tabletDSLD:270908
  • DCMarine Caroteneamount not statedper 1 softgelDSLD:266113
  • DCMarine Carotene1.0%amount not statedper 1 softgelDSLD:331331
  • Douglas LaboratoriesOcu-Min Forteamount not statedper 6 tabletsDSLD:10104
  • Douglas LaboratoriesOcu-Min Forteamount not statedper 6 tabletsDSLD:31006
  • Drucker LabsintraKID All-In-One All Natural Raspberry Flavoramount not statedper 0.5 fl. Oz.DSLD:31428
  • Everett LaboratoriesStrovite One Caplets Iron Freeamount not statedper 1 capletDSLD:82337
  • GNCMultivitamin10 µgper 2 beige capletsDSLD:260119
  • GNCWomen's Ultra Mega without Iron10 µgper 2 light green capletsDSLD:331496
  • GNC AMP Advanced Muscle PerformanceMega Men Sport Multivitamin10 µgper 2 mocha brown capletsDSLD:183541
Show the remaining 159Show the first 12

Label record: NIH Office of Dietary Supplements · CC0

07 · the record

Sources

7

papers screened for beta-cryptoxanthin

admitted
1
read and discarded
5
not read yet
1

The screening record, every paper and why

Sources cited

1 paper · 1 finding

Show every paper citedHide the papers cited

Other names · 2

cryptoxanthin

systematic · (3R)-β,β-caroten-3-ol